1. 2011
  2. DNA damage-induced transcriptional program in CLL: biological and diagnostic implications for functional p53 testing

    Mohr, J., Helfrich, H., Fuge, M., Eldering, E., Bühler, A., Winkler, D., Volden, M., Kater, A. P., Mertens, D., te Raa, D., Döhner, H., Stilgenbauer, S. & Zenz, T., 2011, In: Blood. 117, 5, p. 1622-1632

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Dutch guidelines for diagnosis and treatment of chronic lymphocytic leukaemia 2011

    Kater, A. P., Wittebol, S., Chamuleau, M. E. D., van Gelder, M. & van Oers, M. H. J., 2011, In: Netherlands journal of medicine. 69, 10, p. 422-429

    Research output: Contribution to journalReview articleAcademicpeer-review

  4. Highlights of the 5th Young Investigators' Meeting on chronic lymphocytic leukemia

    Fischer, K., Shanafelt, T. & Kater, A. P., 2011, In: Leukemia & lymphoma. 52, 7, p. 1391-1393

    Research output: Contribution to journalEditorialAcademicpeer-review

  5. Intracerebral Infiltration As the Unique Cause of the Clinical Presentation of Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia

    Tonino, S. H., Rijssenbeek, A. L., Oud, M. E., Pals, S. T., van Oers, M. H. & Kater, A. P., 2011, In: Journal of clinical oncology. 29, 34, p. E837-E839

    Research output: Contribution to journalArticleAcademicpeer-review

  6. Richtlijnen diagnostiek en behandeling chronische lymfatische leukemie 2011

    Kater, A. P., Wittebol, S., Chamuleau, M. E., van Gelder, M. & van Oers, M. H., 2011, In: Nederlands tijdschrift voor hematologie. 8, p. 190-201

    Research output: Contribution to journalArticleProfessional

  7. ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia

    Tonino, S. H., van Laar, J., van Oers, M. H., Wang, J. Y., Eldering, E. & Kater, A. P., 2011, In: Oncogene. 30, 6, p. 701-713

    Research output: Contribution to journalArticleAcademicpeer-review

  8. Use of the CD19 count in a primary care laboratory as a screening method for B-cell chronic lymphoproliferative disorders in asymptomatic patients with lymphocytosis

    te Raa, G. D., Fischer, K., Verweij, W., van Houte, A. J., Kater, A. P. & Biesma, D. H., 2011, In: Clinical chemistry and laboratory medicine. 49, 1, p. 115-120

    Research output: Contribution to journalArticleAcademicpeer-review

  9. Voor welke patiënten wordt ofatumumab vergoed?

    Kater, A. P., 2011, In: HEMATOLOGIE ACTUEEL. 11, 5, p. onbekend

    Research output: Contribution to journalArticleProfessional

  10. Waxing and waning intravascular large cell lymphoma with widespread organ infiltration

    Vos, J. M. I., Bordbar, A., Vet, R., Pals, S. T. & Kater, A. P., 2011, In: Leukemia & lymphoma. 52, 4, p. 705-708

    Research output: Contribution to journalComment/Letter to the editorAcademic

  11. 2010
  12. Chronic lymphocytic leukemia of Eμ-TCL1 transgenic mice undergoes rapid cell turnover that can be offset by extrinsic CD257 to accelerate disease progression (Blood (2009) 114, 20 (4469-4476))

    Enzler, T., Kater, A. P. & Zhang, W., 29 Jul 2010, In: Blood. 116, 4, p. 671 1 p.

    Research output: Contribution to journalComment/Letter to the editorAcademic

ID: 64520